0001387131-19-009327.txt : 20191204
0001387131-19-009327.hdr.sgml : 20191204
20191204070027
ACCESSION NUMBER: 0001387131-19-009327
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191203
FILED AS OF DATE: 20191204
DATE AS OF CHANGE: 20191204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEDERMAN SETH
CENTRAL INDEX KEY: 0001563420
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36019
FILM NUMBER: 191267333
MAIL ADDRESS:
STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP
STREET 2: 509 MADISON AVE., SUITE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp.
CENTRAL INDEX KEY: 0001430306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261434750
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 509 MADISON AVE. - SUITE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 1-800-849-7894
MAIL ADDRESS:
STREET 1: 509 MADISON AVE. - SUITE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC.
DATE OF NAME CHANGE: 20080320
4
1
lederman-form4_120319.xml
OWNERSHIP DOCUMENT
X0306
4
2019-12-03
0
0001430306
Tonix Pharmaceuticals Holding Corp.
TNXP
0001563420
LEDERMAN SETH
C/O TONIX PHARMACEUTICALS HOLDING CORP
509 MADISON AVENUE, SUITE 1608
NEW YORK
NY
10022
1
1
0
0
Chief Executive Officer
Common Stock, $0.001 par value
2019-12-03
4
P
0
20000
1.159
A
23267
I
By 401(k) plan
Common Stock, $0.001 par value
459
I
By IRA Account
Common Stock, $0.001 par value
177
D
Common Stock, $0.001 par value
31
I
By spouse
Common Stock, $0.001 par value
30
I
By Leder Laboratories, Inc.
Common Stock, $0.001 par value
30
I
By Starling Pharmaceuticals, Inc.
Common Stock, $0.001 par value
205
I
By Lederman & Co., LLC
Common Stock, $0.001 par value
33
I
By L&L Technologies, LLC
Common Stock, $0.001 par value
59
I
By Targent Pharmaceuticals, LLC
The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $1.15 to $1.16, inclusive. The reporting person undertakes to provide to Tonix Pharmaceuticals Holding Corp., any security holder of Tonix Pharmaceuticals Holding Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
Reporting person may be deemed to be a control person of this entity.
/s/ Seth Lederman
2019-12-04